BOTANIX PHARMACEUTICALS LTD - Announcements

Market Cap $433.1M Add to my watchlist

Healthcare

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Combining science, nature and human compassion, Little Green Pharma (ASX:LGP) are committed to improving the quality of life for sufferers of debilitating chronic conditions. NEWS: Little Green Pharma shares surge as Germany legalises Cannabis.

Announcements

Filter Results

All Price Sensitive Only

BOT	Notice of Annual General Meeting/Proxy Form		27/09/19	1.13MB	Share
BOT	Botanix Investor Presentation		17/09/19	1.76MB	Share
BOT	Botanix announces new clinical program to target rosacea	PRICE SENSITIVE	16/09/19	898.27KB	Share
BOT	Botanix Presents at International Cannabinoid Summit		13/09/19	2.22MB	Share
BOT	Appendix 3B		12/09/19	725.43KB	Share
BOT	BOT antimicrobial data presented at ASM-ESCMID Conference		06/09/19	236.03KB	Share
BOT	Appendix 3B		04/09/19	286.85KB	Share
BOT	Final Director's Interest Notice MC		26/08/19	198.77KB	Share
BOT	Director Temporary Leave of Absence		23/08/19	197.65KB	Share
BOT	Appendix 4G		20/08/19	181.67KB	Share
BOT	Appendix 4E and Annual Report	PRICE SENSITIVE	20/08/19	1022.01KB	Share
BOT	Change in substantial holding		09/08/19	95.69KB	Share
BOT	Change in substantial holding		09/08/19	588.29KB	Share
BOT	Completion of Placement		09/08/19	168.48KB	Share
BOT	Appendix 3B and Notice Under Section 708A		09/08/19	374.14KB	Share
BOT	Placement Update		07/08/19	186.99KB	Share
BOT	Appendix 3B and Notice Under Section 708A		07/08/19	374.59KB	Share
BOT	Botanix $40 Million US Lead Placement and Management Update	PRICE SENSITIVE	01/08/19	193.2KB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/19	397.02KB	Share
BOT	Trading Halt	PRICE SENSITIVE	30/07/19	360.81KB	Share
BOT	Initial Director's Interest Notice		23/07/19	133.92KB	Share
BOT	Change of Director's Interest Notice MT		23/07/19	342.13KB	Share
BOT	Appendix 3B		18/07/19	285.61KB	Share
BOT	Vince Ippolito appointed as Botanix Executive Chairman		18/07/19	152.65KB	Share
BOT	Results of Meeting		18/07/19	462.52KB	Share
BOT	Exercise Price of Options		18/07/19	147.06KB	Share
BOT	Botanix Antimicrobial Platform Addresses Global Threat	PRICE SENSITIVE	15/07/19	271.04KB	Share
BOT	Appendix 3B		28/06/19	285.27KB	Share
BOT	Media Interview with Botanix President		27/06/19	187.69KB	Share
BOT	New BTX 1801 Data Presented at ASM Microbe 2019		24/06/19	198.9KB	Share
BOT	Updated Investor Presentation with New BTX 1801 Data		20/06/19	2.04MB	Share
BOT	BTX 1801 Kills Superbugs Without Resistance World-First	PRICE SENSITIVE	20/06/19	229.76KB	Share
BOT	Study Confirms Anti-inflammatory and Other Properties of CBD	PRICE SENSITIVE	19/06/19	866.27KB	Share
BOT	Trading Halt	PRICE SENSITIVE	18/06/19	242.68KB	Share
BOT	Pause in Trade	PRICE SENSITIVE	18/06/19	118.21KB	Share
BOT	Notice of General Meeting/Proxy Form		17/06/19	1005.44KB	Share
BOT	Appendix 3B		17/06/19	285.67KB	Share
BOT	Advisory Board Presentation on Psoriasis Market Opportunity		14/06/19	1.62MB	Share
BOT	Appendix 3B Amended		13/06/19	285.8KB	Share
BOT	Appendix 3B		13/06/19	285.42KB	Share
BOT	Botanix at the Jefferies Healthcare Conference		06/06/19	2.12MB	Share
BOT	Appendix 3B		31/05/19	285.32KB	Share
BOT	Appendix 3B		20/05/19	285.53KB	Share
BOT	Dermatology Industry Leader Joins Botanix	PRICE SENSITIVE	20/05/19	504.05KB	Share
BOT	Botanix Provides Retraction in Presentation	PRICE SENSITIVE	16/05/19	470.8KB	Share
BOT	Trading Halt	PRICE SENSITIVE	16/05/19	242.55KB	Share
BOT	Pause In Trading	PRICE SENSITIVE	16/05/19	117.85KB	Share
BOT	Botanix Presenting at Canaccord Genuity Cannabis Conference		14/05/19	1.52MB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	30/04/19	375.19KB	Share
BOT	Appendix 3B		18/04/19	285.68KB	Share
BOT	Appendix 3B and Notice Under Section 708A		18/03/19	300.59KB	Share
BOT	Details of Company Address		13/03/19	121.94KB	Share
BOT	Updated Investor Presentation		04/03/19	1.64MB	Share
BOT	Opinion Leaders Present Botanix Data at AAD 2019		04/03/19	481.6KB	Share
BOT	Appendix 3B		28/02/19	284.24KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19	390.01KB	Share
BOT	Permetrex Outperforms Other CBD Topical Products	PRICE SENSITIVE	26/02/19	8.72MB	Share
BOT	Change of Director's Interest Notice SW		26/02/19	216.01KB	Share
BOT	Appendix 3B		22/02/19	284.69KB	Share
BOT	Initial Director's Interest Notice SW		21/02/19	310.55KB	Share
BOT	Appointment of Non-Executive Chairman Dr Stewart Washer		21/02/19	466.17KB	Share
BOT	Initial Director's Interest Notice MT		15/02/19	134.1KB	Share
BOT	Appointment of Executive Director Dr Michael Thurn		12/02/19	125.39KB	Share
BOT	Final Director's Interest Notice		11/02/19	202.53KB	Share
BOT	Passing of Non-Executive Chairman Mr Graham Griffiths		08/02/19	114.1KB	Share
BOT	2019 Outlook Presentation		31/01/19	2.54MB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/19	839.2KB	Share
BOT	Investigators Meeting Completed for BTX 1204 Phase 2 Study	PRICE SENSITIVE	25/01/19	178.7KB	Share
BOT	Ethics Approval for Phase 2 Atopic Dermatitis Study Received	PRICE SENSITIVE	18/12/18	177.02KB	Share
BOT	Botanix Presents at International Cannabinoid Summit		14/12/18	8.3MB	Share
BOT	Appendix 3B		06/12/18	283.16KB	Share
BOT	Investor Presentation		05/12/18	2.13MB	Share
BOT	Botanix receives A$4.6m R&D Tax Incentive refund	PRICE SENSITIVE	23/11/18	151.28KB	Share
BOT	Results of Meeting		19/11/18	127.18KB	Share
BOT	Annual General Meeting Chairmans Address		19/11/18	140.02KB	Share
BOT	Investor Presentation		15/11/18	2.17MB	Share
BOT	First Patient Treated in BTX 1308 Psoriasis Patient Study	PRICE SENSITIVE	07/11/18	197.52KB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/18	350.81KB	Share
BOT	Notice of Annual General Meeting/Proxy Form		19/10/18	949.43KB	Share
BOT	Botanix Presents at Fall Clinical Dermatology Conference		19/10/18	1.01MB	Share
BOT	Ethics Approval for BTX 1308 Psoriasis Patient Study Secured	PRICE SENSITIVE	27/09/18	106.68KB	Share
BOT	Appendix 4G		21/09/18	111.29KB	Share
BOT	Annual Report to shareholders		21/09/18	686.81KB	Share
BOT	Botanix presents at European Dermatology Conference		13/09/18	1.16MB	Share
BOT	Botanix BTX 1503 Clinical Trial Update	PRICE SENSITIVE	12/09/18	151.01KB	Share
BOT	Pause in trading	PRICE SENSITIVE	12/09/18	117.1KB	Share
BOT	Preliminary Final Report	PRICE SENSITIVE	31/08/18	258.87KB	Share
BOT	FDA Clears Development Path for BTX 1204	PRICE SENSITIVE	30/08/18	131.96KB	Share
BOT	Updated Investor Presentation Revised		13/08/18	1.05MB	Share
BOT	Updated Investor Presentation		13/08/18	1.02MB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/18	590.1KB	Share
BOT	Botanix Expands Clinical Capabilities		27/07/18	107.97KB	Share
BOT	Investigators Meeting Completed for BTX 1503 Phase 2 Trial	PRICE SENSITIVE	23/07/18	111.27KB	Share
BOT	Botanix Joins with UQ to Accelerate Development of BTX 1801	PRICE SENSITIVE	19/07/18	207.21KB	Share
BOT	Appendix 3B		16/07/18	111.67KB	Share
BOT	Botanix update on development pipeline products	PRICE SENSITIVE	02/07/18	937.48KB	Share
BOT	Release of Securities from Escrow		29/06/18	87.82KB	Share
BOT	Change in substantial holding		27/06/18	594.44KB	Share
BOT	Change in substantial holding		27/06/18	45.99KB	Share
BOT	Completion of Placement		27/06/18	143.12KB	Share

BOT Notice of Annual General Meeting/Proxy Form
27/09/19		1.13MB	Share
BOT Botanix Investor Presentation
17/09/19		1.76MB	Share
BOT Botanix announces new clinical program to target rosacea
16/09/19	PRICE SENSITIVE	898.27KB	Share
BOT Botanix Presents at International Cannabinoid Summit
13/09/19		2.22MB	Share
BOT Appendix 3B
12/09/19		725.43KB	Share
BOT BOT antimicrobial data presented at ASM-ESCMID Conference
06/09/19		236.03KB	Share
BOT Appendix 3B
04/09/19		286.85KB	Share
BOT Final Director's Interest Notice MC
26/08/19		198.77KB	Share
BOT Director Temporary Leave of Absence
23/08/19		197.65KB	Share
BOT Appendix 4G
20/08/19		181.67KB	Share
BOT Appendix 4E and Annual Report
20/08/19	PRICE SENSITIVE	1022.01KB	Share
BOT Change in substantial holding
09/08/19		95.69KB	Share
BOT Change in substantial holding
09/08/19		588.29KB	Share
BOT Completion of Placement
09/08/19		168.48KB	Share
BOT Appendix 3B and Notice Under Section 708A
09/08/19		374.14KB	Share
BOT Placement Update
07/08/19		186.99KB	Share
BOT Appendix 3B and Notice Under Section 708A
07/08/19		374.59KB	Share
BOT Botanix $40 Million US Lead Placement and Management Update
01/08/19	PRICE SENSITIVE	193.2KB	Share
BOT Appendix 4C - Quarterly
31/07/19	PRICE SENSITIVE	397.02KB	Share
BOT Trading Halt
30/07/19	PRICE SENSITIVE	360.81KB	Share
BOT Initial Director's Interest Notice
23/07/19		133.92KB	Share
BOT Change of Director's Interest Notice MT
23/07/19		342.13KB	Share
BOT Appendix 3B
18/07/19		285.61KB	Share
BOT Vince Ippolito appointed as Botanix Executive Chairman
18/07/19		152.65KB	Share
BOT Results of Meeting
18/07/19		462.52KB	Share
BOT Exercise Price of Options
18/07/19		147.06KB	Share
BOT Botanix Antimicrobial Platform Addresses Global Threat
15/07/19	PRICE SENSITIVE	271.04KB	Share
BOT Appendix 3B
28/06/19		285.27KB	Share
BOT Media Interview with Botanix President
27/06/19		187.69KB	Share
BOT New BTX 1801 Data Presented at ASM Microbe 2019
24/06/19		198.9KB	Share
BOT Updated Investor Presentation with New BTX 1801 Data
20/06/19		2.04MB	Share
BOT BTX 1801 Kills Superbugs Without Resistance World-First
20/06/19	PRICE SENSITIVE	229.76KB	Share
BOT Study Confirms Anti-inflammatory and Other Properties of CBD
19/06/19	PRICE SENSITIVE	866.27KB	Share
BOT Trading Halt
18/06/19	PRICE SENSITIVE	242.68KB	Share
BOT Pause in Trade
18/06/19	PRICE SENSITIVE	118.21KB	Share
BOT Notice of General Meeting/Proxy Form
17/06/19		1005.44KB	Share
BOT Appendix 3B
17/06/19		285.67KB	Share
BOT Advisory Board Presentation on Psoriasis Market Opportunity
14/06/19		1.62MB	Share
BOT Appendix 3B Amended
13/06/19		285.8KB	Share
BOT Appendix 3B
13/06/19		285.42KB	Share
BOT Botanix at the Jefferies Healthcare Conference
06/06/19		2.12MB	Share
BOT Appendix 3B
31/05/19		285.32KB	Share
BOT Appendix 3B
20/05/19		285.53KB	Share
BOT Dermatology Industry Leader Joins Botanix
20/05/19	PRICE SENSITIVE	504.05KB	Share
BOT Botanix Provides Retraction in Presentation
16/05/19	PRICE SENSITIVE	470.8KB	Share
BOT Trading Halt
16/05/19	PRICE SENSITIVE	242.55KB	Share
BOT Pause In Trading
16/05/19	PRICE SENSITIVE	117.85KB	Share
BOT Botanix Presenting at Canaccord Genuity Cannabis Conference
14/05/19		1.52MB	Share
BOT Appendix 4C - Quarterly
30/04/19	PRICE SENSITIVE	375.19KB	Share
BOT Appendix 3B
18/04/19		285.68KB	Share
BOT Appendix 3B and Notice Under Section 708A
18/03/19		300.59KB	Share
BOT Details of Company Address
13/03/19		121.94KB	Share
BOT Updated Investor Presentation
04/03/19		1.64MB	Share
BOT Opinion Leaders Present Botanix Data at AAD 2019
04/03/19		481.6KB	Share
BOT Appendix 3B
28/02/19		284.24KB	Share
BOT Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE	390.01KB	Share
BOT Permetrex Outperforms Other CBD Topical Products
26/02/19	PRICE SENSITIVE	8.72MB	Share
BOT Change of Director's Interest Notice SW
26/02/19		216.01KB	Share
BOT Appendix 3B
22/02/19		284.69KB	Share
BOT Initial Director's Interest Notice SW
21/02/19		310.55KB	Share
BOT Appointment of Non-Executive Chairman Dr Stewart Washer
21/02/19		466.17KB	Share
BOT Initial Director's Interest Notice MT
15/02/19		134.1KB	Share
BOT Appointment of Executive Director Dr Michael Thurn
12/02/19		125.39KB	Share
BOT Final Director's Interest Notice
11/02/19		202.53KB	Share
BOT Passing of Non-Executive Chairman Mr Graham Griffiths
08/02/19		114.1KB	Share
BOT 2019 Outlook Presentation
31/01/19		2.54MB	Share
BOT Appendix 4C - Quarterly
31/01/19	PRICE SENSITIVE	839.2KB	Share
BOT Investigators Meeting Completed for BTX 1204 Phase 2 Study
25/01/19	PRICE SENSITIVE	178.7KB	Share
BOT Ethics Approval for Phase 2 Atopic Dermatitis Study Received
18/12/18	PRICE SENSITIVE	177.02KB	Share
BOT Botanix Presents at International Cannabinoid Summit
14/12/18		8.3MB	Share
BOT Appendix 3B
06/12/18		283.16KB	Share
BOT Investor Presentation
05/12/18		2.13MB	Share
BOT Botanix receives A$4.6m R&D Tax Incentive refund
23/11/18	PRICE SENSITIVE	151.28KB	Share
BOT Results of Meeting
19/11/18		127.18KB	Share
BOT Annual General Meeting Chairmans Address
19/11/18		140.02KB	Share
BOT Investor Presentation
15/11/18		2.17MB	Share
BOT First Patient Treated in BTX 1308 Psoriasis Patient Study
07/11/18	PRICE SENSITIVE	197.52KB	Share
BOT Appendix 4C - Quarterly
31/10/18	PRICE SENSITIVE	350.81KB	Share
BOT Notice of Annual General Meeting/Proxy Form
19/10/18		949.43KB	Share
BOT Botanix Presents at Fall Clinical Dermatology Conference
19/10/18		1.01MB	Share
BOT Ethics Approval for BTX 1308 Psoriasis Patient Study Secured
27/09/18	PRICE SENSITIVE	106.68KB	Share
BOT Appendix 4G
21/09/18		111.29KB	Share
BOT Annual Report to shareholders
21/09/18		686.81KB	Share
BOT Botanix presents at European Dermatology Conference
13/09/18		1.16MB	Share
BOT Botanix BTX 1503 Clinical Trial Update
12/09/18	PRICE SENSITIVE	151.01KB	Share
BOT Pause in trading
12/09/18	PRICE SENSITIVE	117.1KB	Share
BOT Preliminary Final Report
31/08/18	PRICE SENSITIVE	258.87KB	Share
BOT FDA Clears Development Path for BTX 1204
30/08/18	PRICE SENSITIVE	131.96KB	Share
BOT Updated Investor Presentation Revised
13/08/18		1.05MB	Share
BOT Updated Investor Presentation
13/08/18		1.02MB	Share
BOT Appendix 4C - Quarterly
31/07/18	PRICE SENSITIVE	590.1KB	Share
BOT Botanix Expands Clinical Capabilities
27/07/18		107.97KB	Share
BOT Investigators Meeting Completed for BTX 1503 Phase 2 Trial
23/07/18	PRICE SENSITIVE	111.27KB	Share
BOT Botanix Joins with UQ to Accelerate Development of BTX 1801
19/07/18	PRICE SENSITIVE	207.21KB	Share
BOT Appendix 3B
16/07/18		111.67KB	Share
BOT Botanix update on development pipeline products
02/07/18	PRICE SENSITIVE	937.48KB	Share
BOT Release of Securities from Escrow
29/06/18		87.82KB	Share
BOT Change in substantial holding
27/06/18		594.44KB	Share
BOT Change in substantial holding
27/06/18		45.99KB	Share
BOT Completion of Placement
27/06/18		143.12KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 27.5¢		Change -0.015(5.17%)		Mkt cap ! $433.1M

Open	High	Low	Value	Volume
28.5¢	29.0¢	27.5¢	$1.164M	4.100M

Buyers (Bids)

No.	Vol.	Price($)
9	534239	27.5¢

Sellers (Offers)

Price($)	Vol.	No.
28.0¢	77302	2

View Market Depth

No.	Vol.	Price($)
9	534239	0.275
28	1101521	0.270
7	245317	0.265
15	539228	0.260
6	281008	0.255

Price($)	Vol.	No.
0.280	77302	2
0.285	206615	3
0.290	236155	4
0.295	251724	4
0.300	400955	9

Last trade - 16.10pm 28/05/2024 (20 minute delay)


Last 28.0¢		Change -0.015 ( 2.61 %)
Open	High	Low	Volume
28.5¢	29.0¢	27.5¢	2348390
Last updated 15.59pm 28/05/2024 ?

BOT (ASX) Chart

BOTANIX PHARMACEUTICALS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories